StockData
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF

Telix Pharmaceuticals Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026
$10.74+0.05 (+0.47%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Telix Pharmaceuticals Ltd revenue by segment

No segment breakdown reported

Telix Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.